For: | Gómez-García M, Cabello-Tapia MJ, Sánchez-Capilla AD, Teresa-Galván JD, Redondo-Cerezo E. Thiopurines related malignancies in inflammatory bowel disease: Local experience in Granada, Spain. World J Gastroenterol 2013; 19(30): 4877-4886 [PMID: 23946592 DOI: 10.3748/wjg.v19.i30.4877] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v19/i30/4877.htm |
Number | Citing Articles |
1 |
Anastasia Mala, Kalliopi Foteinogiannopoulou, Ioannis E Koutroubakis. Solid extraintestinal malignancies in patients with inflammatory bowel disease. World Journal of Gastrointestinal Oncology 2021; 13(12): 1956-1980 doi: 10.4251/wjgo.v13.i12.1956
|
2 |
Steven C Lin, Alex Goldowsky, Konstantinos Papamichael, Adam S Cheifetz. The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy. Inflammatory Bowel Diseases 2019; 25(6): 998 doi: 10.1093/ibd/izy376
|
3 |
Manuel Barreiro-de Acosta, Alberto Molero, Esther Artime, Silvia Díaz-Cerezo, Luis Lizán, Héctor David de Paz, María Dolores Martín-Arranz. Epidemiological, Clinical, Patient-Reported and Economic Burden of Inflammatory Bowel Disease (Ulcerative colitis and Crohn’s disease) in Spain: A Systematic Review. Advances in Therapy 2023; 40(5): 1975 doi: 10.1007/s12325-023-02473-6
|
4 |
Cho-Hsun Hsieh, Yi-Wei Huang, Tsen-Fang Tsai. Oral Conventional Synthetic Disease-Modifying Antirheumatic Drugs with Antineoplastic Potential: a Review. Dermatology and Therapy 2022; 12(4): 835 doi: 10.1007/s13555-022-00713-1
|
5 |
Won Moon, Jae Jun Park. Risks of Cancer Associated with Therapeutic Drugs for Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2024; 83(6): 233 doi: 10.4166/kjg.2024.053
|
6 |
Jianfeng Gong, Lijing Zhu, Zhen Guo, Yi Li, Weiming Zhu, Ning Li, Jieshou Li, Christopher R. Weber. Use of Thiopurines and Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Diseases: A Meta-Analysis. PLoS ONE 2013; 8(11): e81487 doi: 10.1371/journal.pone.0081487
|
7 |
Florian Poullenot, Philippe Seksik, Laurent Beaugerie, Aurélien Amiot, Maria Nachury, Vered Abitbol, Carmen Stefanescu, Catherine Reenaers, Mathurin Fumery, Anne-Laure Pelletier, Stephane Nancey, Laurent Peyrin-Biroulet, Arnaud Bourreille, Xavier Hébuterne, Hedia Brixi, Guillaume Savoye, Nelson Lourenço, Romain Altwegg, Anthony Buisson, Christine Cazelles-Boudier, Antoine Racine, Julien Vergniol, David Laharie. Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy. Inflammatory Bowel Diseases 2016; 22(6): 1362 doi: 10.1097/MIB.0000000000000741
|
8 |
Hsien‐Chung Yu. Primary colonic lymphoma in patients with inflammatory bowel disease: Is it treatment‐ or disease‐related adverse event?. Advances in Digestive Medicine 2020; 7(4): 177 doi: 10.1002/aid2.13263
|
9 |
Vito Annese, Laurent Beaugerie, Laurence Egan, Livia Biancone, Claus Bolling, Christian Brandts, Daan Dierickx, Reinhard Dummer, Gionata Fiorino, Jean Marc Gornet, Peter Higgins, Konstantinos H Katsanos, Loes Nissen, Gianluca Pellino, Gerhard Rogler, Franco Scaldaferri, Edyta Szymanska, Rami Eliakim. European Evidence-based Consensus: Inflammatory Bowel Disease and Malignancies. Journal of Crohn's and Colitis 2015; 9(11): 945 doi: 10.1093/ecco-jcc/jjv141
|
10 |
Joshua W. Hagen, Melissa A. Pugliano-Mauro. Nonmelanoma Skin Cancer Risk in Patients With Inflammatory Bowel Disease Undergoing Thiopurine Therapy: A Systematic Review of the Literature. Dermatologic Surgery 2018; 44(4): 469 doi: 10.1097/DSS.0000000000001455
|
11 |
Hannah Gordon, Livia Biancone, Gionata Fiorino, Konstantinos H Katsanos, Uri Kopylov, Eman Al Sulais, Jordan E Axelrad, Karthiha Balendran, Johan Burisch, Lissy de Ridder, Lauranne Derikx, Pierre Ellul, Thomas Greuter, Marietta Iacucci, Caroline Di Jiang, Christina Kapizioni, Konstantinos Karmiris, Julien Kirchgesner, David Laharie, Triana Lobatón, Tamás Molnár, Nurulamin M Noor, Rohit Rao, Simone Saibeni, Michael Scharl, Stephan R Vavricka, Tim Raine. ECCO Guidelines on Inflammatory Bowel Disease and Malignancies. Journal of Crohn's and Colitis 2023; 17(6): 827 doi: 10.1093/ecco-jcc/jjac187
|
12 |
M. J. Lu, X. Y. Qiu, X. Q. Mao, X. T. Li, H. J. Zhang. Systematic review with meta‐analysis: thiopurines decrease the risk of colorectal neoplasia in patients with inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 2018; 47(3): 318 doi: 10.1111/apt.14436
|
13 |
Shao‐Zhuo Huang, Zhi‐Cheng Liu, Wei‐Xin Liao, Jun‐Xiao Wei, Xiao‐Wen Huang, Chen Yang, Yu‐Han Xia, Lu Li, Chao Ye, Shi‐Xue Dai. Risk of skin cancers in thiopurines‐treated and thiopurines‐untreated patients with inflammatory bowel disease: A systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 2019; 34(3): 507 doi: 10.1111/jgh.14533
|
14 |
Zhehui Zhu, Zubing Mei, Yuegui Guo, Guanghui Wang, Tingyu Wu, Ximao Cui, Zhenyu Huang, Yilian Zhu, Dongpeng Wen, Jinglve Song, Hailan He, Weimin Xu, Long Cui, Chenying Liu. Reduced Risk of Inflammatory Bowel Disease-associated Colorectal Neoplasia with Use of Thiopurines: a Systematic Review and Meta-analysis. Journal of Crohn's and Colitis 2018; 12(5): 546 doi: 10.1093/ecco-jcc/jjy006
|
15 |
Alessandro Massano, Luisa Bertin, Fabiana Zingone, Andrea Buda, Pierfrancesco Visaggi, Lorenzo Bertani, Nicola de Bortoli, Matteo Fassan, Marco Scarpa, Cesare Ruffolo, Imerio Angriman, Cristina Bezzio, Valentina Casini, Davide Giuseppe Ribaldone, Edoardo Vincenzo Savarino, Brigida Barberio. Extraintestinal Cancers in Inflammatory Bowel Disease: A Literature Review. Cancers 2023; 15(15): 3824 doi: 10.3390/cancers15153824
|
16 |
Hanna M J L Hazenberg, Nanne K H de Boer, Chris J J Mulder, Stijn H Mom, Ad A van Bodegraven, Greetje J Tack. Neoplasia and Precursor Lesions of the Female Genital Tract in IBD: Epidemiology, Role of Immunosuppressants, and Clinical Implications. Inflammatory Bowel Diseases 2018; 24(3): 510 doi: 10.1093/ibd/izx062
|